Shalini , K., F, M., M, J., T, H., U, U., N, J., T , A., A, K., B, S., J , H., BA, C., BP , S., D , R., AH , K., A, B., B, A., S, N. A., B, H., W, K., … N, S. (2024). To Assess the Efficacy and Safety of Fixed-Dose Combination of Teneligliptin and Pioglitazone (Tiban P) in Iraqi Patients with Type 2 Diabetes Mellitus. International Journal of Research in Pharmacy and Life Sciences, 12(02), 31-37. https://doi.org/10.30904/j.ijrpls.2024.4722